Cita APA

Hidalgo-Tenorio, C., Pasquau, J., Vinuesa, D., Ferra, S., Terron, A., SanJoaquin, I., . . . Garcia-Vallecillos, C. (2022). DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks).

Citación estilo Chicago

Hidalgo-Tenorio, Carmen, et al. DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks). 2022.

Cita MLA

Hidalgo-Tenorio, Carmen, et al. DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks). 2022.